Lab21 Ltd. is a rapidly growing healthcare diagnostics business, founded in 2005 and headquartered in the United Kingdom. The company's vision is to provide personalized diagnostic testing for disease identification, disease predisposition, and personalized medicine, emphasizing the importance of prevention over cure. Lab21 operates in two main trading divisions.
The first division focuses on molecular diagnostic testing services, particularly for patients needing diagnosis and optimized treatment in areas such as cancer and virology. Lab21's offerings encompass a wide range of services, including the handling of infectious samples in its Category 3 containment facilities. Notably, the company leads the market in providing companion diagnostic services and collaborates closely with major pharmaceutical companies. Furthermore, the company's reference lab is fully accredited for handling patient and clinical trial samples, and it has developed robust logistic services to transport samples globally. Lab21 also boasts significant experience in developing and commercializing new biomarker assays using its own or partner intellectual property.
The second division centers on proprietary manufactured antibody and antigen-based products for infectious diseases, such as syphilis, CMV, TB, and malaria, which are distributed in worldwide blood banking and diagnostic product markets. The company's portfolio is continuously expanding, with a range of proprietary new and improved immuno- and molecular diagnostic products sold in over 100 countries through a combination of direct and indirect distribution channels.
Lab21's impressive growth has been underscored by a recent £5.00M Venture Round investment in August 29, 2012, led by Clydesdale Bank. The company enjoys a strong position with four UK-based sites and the impending establishment of its US headquarters in South Carolina. With its revenues tripling in 2009 and a proactive strategy combining organic and acquisitive growth, Lab21 is poised for sustained success in the biotechnology, healthcare, and information technology industries.
